These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19222148)

  • 21. FDA notifications. Combination lamivudine and tenofovir tablet approved.
    AIDS Alert; 2010 Jan; 25(1):10. PubMed ID: 20140989
    [No Abstract]   [Full Text] [Related]  

  • 22. FDA notifications. Generic efavirenz capsules tentatively approved by FDA.
    AIDS Alert; 2009 Dec; 24(12):143. PubMed ID: 20063479
    [No Abstract]   [Full Text] [Related]  

  • 23. FDA notifications. Generic zidovudine oral solution approved.
    AIDS Alert; 2008 Aug; 23(8):90. PubMed ID: 18724489
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA notifications. FDA grants approval of generic lamivudine tablets.
    AIDS Alert; 2009 Dec; 24(12):142-3. PubMed ID: 20063478
    [No Abstract]   [Full Text] [Related]  

  • 25. FDA notifications. FDA approves generic stavudine.
    AIDS Alert; 2009 Mar; 24(3):34. PubMed ID: 19441156
    [No Abstract]   [Full Text] [Related]  

  • 26. FDA notifications. FDA grants accelerated approval for etravirine.
    AIDS Alert; 2008 Mar; 23(3):34-5. PubMed ID: 18661641
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA notifications. Generic stavudine and efavirenz are tentatively approved by FDA.
    AIDS Alert; 2008 Apr; 23(4):46. PubMed ID: 19253455
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA notifications. Large study suggests heart attack risk from use of abacavir or didanosine.
    AIDS Alert; 2008 May; 23(5):58-9. PubMed ID: 18642404
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA notifications. FDA approval for generic lamivudine/zidovudine.
    AIDS Alert; 2008 Jan; 23(1):12. PubMed ID: 18572476
    [No Abstract]   [Full Text] [Related]  

  • 30. FDA notifications. NRTI Emtriva receives FDA approval.
    AIDS Alert; 2003 Oct; 18(10):131-2. PubMed ID: 14686301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA notifications. Tentative approval granted of generic nevirapine.
    AIDS Alert; 2007 Sep; 22(9):104-5. PubMed ID: 18415956
    [No Abstract]   [Full Text] [Related]  

  • 32. FDA notifications. Complera approved.
    AIDS Alert; 2011 Nov; 26(11):130-1. PubMed ID: 22164521
    [No Abstract]   [Full Text] [Related]  

  • 33. FDA notifications. Two tenofovir containing products are approved.
    AIDS Alert; 2006 Jun; 21(6):71. PubMed ID: 16795142
    [No Abstract]   [Full Text] [Related]  

  • 34. FDA notifications. FDA tentatively approves fixed-dose lamivudine/zidovudine.
    AIDS Alert; 2010 Dec; 25(12):142-3. PubMed ID: 21328815
    [No Abstract]   [Full Text] [Related]  

  • 35. FDA notifications. Tentative approval for lamivudine.
    AIDS Alert; 2009 Aug; 24(8):93-4. PubMed ID: 19708084
    [No Abstract]   [Full Text] [Related]  

  • 36. FDA notifications. FDA approves generic lamivudine.
    AIDS Alert; 2008 Dec; 23(12):142. PubMed ID: 19110688
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA notifications. FDA tentatively approves generic lamivudine.
    AIDS Alert; 2007 May; 22(5):57. PubMed ID: 17580368
    [No Abstract]   [Full Text] [Related]  

  • 38. FDA notifications. FDA tentatively approves efavirenz cross-scored tablets.
    AIDS Alert; 2010 Apr; 25(4):45. PubMed ID: 20560191
    [No Abstract]   [Full Text] [Related]  

  • 39. FDA notifications. Tentative approval of generic lamivudine.
    AIDS Alert; 2005 Jul; 20(7):82. PubMed ID: 16114112
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA notifications. FDA approves pediatric efficacy supplement for didanosine capsules.
    AIDS Alert; 2008 Nov; 23(11):129. PubMed ID: 19043871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.